Thus, the similarlity of the T cell-derived cytokines reflect the disease state, distinguishing between HC and MS patients (untreated and IFNb treated), while the innate cytokines reflect the tolerogenic capacity of the IL-27-pretreated mDCs (HCs and IFNb-treated patients). Here, IFNB1 is linked to myeloid sarcoma.